Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

Status Completed

Clinical Trial Summary

This is a retrospective biobank study evaluating the impact of novel genetic variants in a population of 6-mercaptopurine treated pediatric acute lymphoblastic leukemia patients.

Clinical Trial Description

The study objective is to clinically validate that the presence of recently discovered novel genetic variation adversely affects a population of 6-mercaptopurine treated pediatric acute lymphoblastic leukemia patients using biobank samples. ;

Study Design

Related Conditions & MeSH terms

Acute Lymphoblastic Leukemia, Pediatric
Adverse Drug Event
Drug-Related Side Effects and Adverse Reactions
Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trial Details

NCT number	NCT04770922
Study type	Observational
Source	Cipherome, Inc.
Contact
Status	Completed
Phase
Start date	February 23, 2021
Completion date	November 10, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03638726` - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification	Phase 4
Completed	`NCT05007041` - Simultaneous RZV and aIIV4 Vaccination	Phase 4
Suspended	`NCT02559960` - Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
Completed	`NCT05266300` - Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
Completed	`NCT03112083` - Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood Pressure	N/A
Completed	`NCT05028361` - Simultaneous mRNA COVID-19 and IIV4 Vaccination Study	Phase 4
Completed	`NCT04284553` - Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults	N/A
Recruiting	`NCT06120712` - A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002)	Phase 1/Phase 2
Completed	`NCT04181775` - Effectiveness of an ADE-related Hospitalization Risk Prediction Tool for Patients (ADE-RED)
Completed	`NCT02906657` - Medication Reconciliation Using Electronic Pharmaceutical Record: A Multicenter Study in the Hospitalized Elderly	N/A
Completed	`NCT03640273` - Efficacy and Adverse Effects of Prapchompoothaweep Remedy and Loratadine for Treatment in AR Patients	Phase 2
Completed	`NCT02162147` - How Safe Are Our Pediatric Emergency Departments?	N/A
Completed	`NCT01897870` - The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge.	N/A
Completed	`NCT03725046` - Impact of an Optimized Communication on the Readmission for Adverse Drug Event	N/A
Recruiting	`NCT04635956` - Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas	Phase 2
Active, not recruiting	`NCT05538065` - NUDGE-EHR Replication Trial at Mass General Brigham	N/A
Completed	`NCT03442010` - Adverse Drug Events at Emergency Department
Recruiting	`NCT04791150` - Rheumatologic Adverse Events and Cancer Immunotherapy	N/A
Completed	`NCT02864030` - PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment	Phase 4
Completed	`NCT03665402` - A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status	N/A